Connect with us

Healthcare Buzz

Lupin, Phil Inc partner to deliver solutions for patients on Solosec

Lupin Pharmaceuticals has partnered with Phil, Inc, which helps deliver cost-effective next-generation access solutions for patients who are prescribed Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. Solosec is the only single 2g oral dose therapy for the most common vaginal infection in the US among adult women. This treatment is designed to deliver a full course of therapy in just one packet.

With the addition of Solosec to the Phil platform, the company is able to provide a convenient channel for physicians to prescribe Solosec and enhance the patient experience.

Copyright © 2023 Medical Buyer

error: Content is protected !!